“…Patient-Oriented Eczema Measure (POEM) scores were measured online by carer report at baseline and at 12 weeks. Qualitative interviews were carried out with 13 HCPs (primarily practice nurses) and 26 participants to explore their experiences of taking part in the study. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Evaluations were performed before and at 2, 4, 8, 16, and 24 weeks after treatment. Pain evaluation was done by Visual Analogue Scale (VAS), Verbal Rating Scale (VRS), Percentage of Pain Relief (PRR), and Global Pain Score (GPS). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…METHODS: In a double-blind, randomized, and crossover manner; 10 recreationally trained males (20 ± 2 yrs; 179 ± 9 cm; 91.3 ± 34 kg) ingested 500 mg of aqueous RT extract (Finzelberg, Andernach, Germany) or 500 mg placebo 30-minutes prior to ingesting 5 g of CrM (Creapure®, AlzChem AG, Germany) twice per day for 5-days then repeated after a 6-week wash-out period. Urine was collected at baseline and during each of the 5-days of supplementation to determine urine Cr content. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…RESULTS: Both WIN55,212-2 and AM1710 blocked the development of paclitaxel-induced mechanical and cold allodynia; anti-allodynic efficacy persisted for approximately two to three weeks following cessation of drug delivery. WIN55,212-2 (0.1 and 0.5 mg/kg/day s.c.) suppressed the development of both paclitaxel-induced mechanical and cold allodynia. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…DESIGN: Participants (N=49, 18–75 years, body mass index: 30–40 kg m(−2)) were randomized to two of three treatments: liraglutide 1.8 mg, 3.0 mg, or placebo in a double-blind, incomplete crossover trial. After 5 weeks, 24-h energy expenditure (EE) and substrate oxidation were measured in a respiratory chamber. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…METHODS: HNSCs were differentiated on 2- (2D) and 3-dimensional (3D) cultures for 1 and 3 weeks. Quantification of hNSC differentiation was measured with real-time PCR and axon outgrowth. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Results: There was decreased expression of thyroid-specific genes such as Tg and NIS and increased expression of stemness markers, such as Oct4, Rex1, CD15, and Sox2 in the thyroid carcinoma tissue from 6-week-old BRAF(V600E) mice indicating the dedifferentiated status of the cells and the fact that stemness was derived in this model from differentiated thyroid cells. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…METHODS: Following a cross-over design, all study participants were interviewed using two data collection methods after a one-week washout period. Questions in the paper-based questionnaires in Thai language were translated to each ethnic language by the interviewer/translator when interviewing the study participant. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Physical activity and eating behavior were assessed by questionnaire during the rehabilitation program and 12 weeks later. Analyses were conducted based on an intention-to-treat and an as-treated protocol. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Postoperative low dose CT was undertaken at 4 weeks after operation to evaluate the acute changes of postoperative lung volumes and pulmonary complications. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Mean (SD) gestational age when infection occurred was 27.5 (7.2) weeks. Among pregnant women, 63.4% (33/52) were in 3(rd) trimester. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…A study of radiation body burden estimation was undertaken in two groups of patients treated with RA(131)I; (a) one group of patients having thyroxine medication suspended for 5 weeks prior to therapy and (b) in the other group retaining thyroxine support with two rhTSH injections prior to therapy with RA(131)I. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…HCV monoinfected group was characterized by higher prevalence of genotype 2 (53% vs 5.3%), higher baseline HCV viral load (50% vs 35%), shorter mean duration of treatment (19 vs 41 weeks), more frequent use of peginterferon alfa-2a (84.5% vs 69.7%), lower prevalence of cirrhosis (6% vs 31.6%). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…METHODS: Patients with unwanted SMF were randomized to receive 1 or 2 mg/cm(2) of ATX-101 or a placebo injected into their SMF during a maximum of four treatment sessions spaced approximately 28 days apart, with a 12-week follow-up period. The proportions of patients with reductions in SMF of one point or more on the Clinician-Reported SMF Rating Scale (CR-SMFRS) and the proportions of patients satisfied with the appearance of their face and chin [Subject Self-Rating Scale (SSRS) score ≥4] were reported overall and in subgroups. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…On two days separated by 1-2 weeks, we measured lung function at the end of the work day, personal PM(2.5), and nine elemental components of PM(2.5) during eight hours of work, i.e., elemental carbon (EC), potassium (K), sulfur (S), iron (Fe), silicon (Si), aluminum (Al), zinc (Zn), calcium (Ca), and titanium (Ti). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…METHODS: Twelve Japanese patients with type 2 diabetes mellitus and dyslipidemia (mean age: 59.5 years; fasting plasma glucose: 7.95 mmol/L; hemoglobin A1c [HbA1c]: 7.3%; body mass index: 26.5 kg/m(2)) underwent a glucose clamp and MTT before and after 12 weeks of treatment with 400 mg/day bezafibrate. The glucose infusion rate was measured during the glucose clamp. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…RESULTS: We collected 471 HCV risk assessment questionnaires during the eight-week period. The median age was 34 (range 18–71) and 403 (85.6%) were White British. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…All patients received ATV in the HAART regimen for 48 weeks. Changes in the total, direct and indirect bilirubin, ALT, AST, GGT and jaundice were evaluated. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Patients received HCV treatment with pegylated interferon (PEG-IFN) and RBV (1000/12,000 mg/day) during 24–48 weeks. RESULTS: SVR was received in 50% of patients with G1 HCV, and 80.1% of patients with Genotypes 2/3 (G2/3; p<0.0001). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Treatment regime was 48 weeks of weight-based ribavirin and pegylated interferon α2a. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso